Gatsounia A, Schinas G, Danielides G, Grafanaki K, Mastronikolis N, Stathopoulos C
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996835
PMC: 11854526.
DOI: 10.3390/cimb47020114.
Toppila-Salmi S, Lyly A, Simin J, Aakko J, Olsen H, Lehtimaki L
Clin Transl Allergy. 2025; 15(2):e70032.
PMID: 39887945
PMC: 11779534.
DOI: 10.1002/clt2.70032.
Costanzo G, Marchetti M, Ledda A, Sambugaro G, Bullita M, Paoletti G
Int J Mol Sci. 2024; 25(23).
PMID: 39684326
PMC: 11641587.
DOI: 10.3390/ijms252312615.
Habenbacher M, Moser U, Abaira A, Kiss P, Holzmeister C, Pock J
Pharmaceutics. 2024; 16(11).
PMID: 39598494
PMC: 11597114.
DOI: 10.3390/pharmaceutics16111370.
Habenbacher M, Moser U, Hadl O, Kiss P, Holzmeister C, Pock J
J Clin Med. 2024; 13(22).
PMID: 39598027
PMC: 11595206.
DOI: 10.3390/jcm13226883.
Women suffering from chronic rhinosinusitis in Norway are more likely to take sick leave.
Clarhed U, Schioler L, Toren K, Fell A, Hellgren J
PLoS One. 2024; 19(11):e0313122.
PMID: 39485771
PMC: 11530087.
DOI: 10.1371/journal.pone.0313122.
Factors Contributing to the Recurrence of Chronic Rhinosinusitis With Nasal Polyps After Endoscopic Sinus Surgery: A Systematic Review.
Abuduruk S, Sabb Gul B, Almasoudi S, Alfattani E, Mohammad M, Alshehri H
Cureus. 2024; 16(8):e67910.
PMID: 39328679
PMC: 11425789.
DOI: 10.7759/cureus.67910.
Impact of Overweight on Response to Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps.
Habenbacher M, Moser U, Abaira A, Tomazic P, Kiss P, Holzmeister C
Nutrients. 2024; 16(17).
PMID: 39275297
PMC: 11397523.
DOI: 10.3390/nu16172982.
Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
Favier V, Daveau C, Carsuzaa F, Fieux M, Vandersteen C, Castillo L
BMJ Open. 2024; 14(5):e083112.
PMID: 38749694
PMC: 11097834.
DOI: 10.1136/bmjopen-2023-083112.
Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights.
Toppila-Salmi S, Bjermer L, Cardell L, Cervin A, Heinikari T, Lehtimaki L
J Asthma Allergy. 2024; 17:431-439.
PMID: 38745838
PMC: 11093112.
DOI: 10.2147/JAA.S447093.
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features.
Fiorentino V, Martini M, Galletti C, Pizzimenti C, Franchina M, Ieni A
J Pers Med. 2024; 14(4).
PMID: 38673041
PMC: 11051558.
DOI: 10.3390/jpm14040414.
Real-Life Study of Patient Preference for Dupilumab or Revision Surgery for Recurrent Chronic Rhinosinusitis with Nasal Polyps.
Gangl K, Liu D, Bartosik T, Campion N, Vyskocil E, Mueller C
J Pers Med. 2024; 14(4).
PMID: 38672965
PMC: 11051141.
DOI: 10.3390/jpm14040338.
Platelet-to-lymphocyte ratio might predict the response to dupilumab treatment for patients with nasal polyposis.
Brkic F, Liu D, Rucklinger I, Campion N, Bartosik T, Vyskocil E
J Otolaryngol Head Neck Surg. 2023; 52(1):75.
PMID: 38007429
PMC: 10676571.
DOI: 10.1186/s40463-023-00660-7.
Orally administered Chinese herbal therapy to assist post-surgical recovery for chronic rhinosinusitis-A systematic review and meta-analysis.
Cui J, Lin W, May B, Luo Q, Worsnop C, Zhang A
PLoS One. 2023; 18(10):e0292138.
PMID: 37797052
PMC: 10553817.
DOI: 10.1371/journal.pone.0292138.
The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.
Campion N, Brugger J, Tu A, Stanek V, Brkic F, Bartosik T
J Otolaryngol Head Neck Surg. 2023; 52(1):56.
PMID: 37674253
PMC: 10481502.
DOI: 10.1186/s40463-023-00663-4.
Real Life Observational Study of Treatment Success of Monoclonal Antibodies for Refractory Chronic Rhinosinusitis with Nasal Polyps.
Gerstacker K, Ketterer M, Jakob T, Hildenbrand T
J Clin Med. 2023; 12(13).
PMID: 37445408
PMC: 10342232.
DOI: 10.3390/jcm12134374.
The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
Haloob N, Karamali K, Hopkins C
BioDrugs. 2023; 37(4):477-487.
PMID: 37318659
DOI: 10.1007/s40259-023-00602-9.
Correlation between ABO Blood Grouping & Allergic Rhinosinusitis with and without Polyposis & Role of TNF-α Polymorphism in Allergic Rhinosinusitis.
Sujata S, Verma V, Chandra M
Indian J Otolaryngol Head Neck Surg. 2023; 75(Suppl 1):705-710.
PMID: 37206858
PMC: 10188700.
DOI: 10.1007/s12070-022-03256-1.
The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids.
Bartosik T, Campion N, Freisl K, Liu D, Gangl K, Stanek V
Front Immunol. 2023; 14:1112345.
PMID: 37122714
PMC: 10140405.
DOI: 10.3389/fimmu.2023.1112345.
Evaluation of Advanced Oxidation Protein Products (AOPP) and Superoxide Dismutase (SOD) Tissue Levels in Patients with Nasal Polyps.
Zorlu M, Uygur K, Yilmaz N, Demirel O, Aydil U, Kizil Y
Indian J Otolaryngol Head Neck Surg. 2023; 74(Suppl 3):4824-4830.
PMID: 36742727
PMC: 9895680.
DOI: 10.1007/s12070-022-03124-y.